Related Experiment Video
Updated: Jul 12, 2025
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
18.3K
Conventional type 1 dendritic cells (cDC1) in cancer immunity
Peng Liu1,2, Liwei Zhao1,2, Guido Kroemer3,4,5
1Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris Cité, Inserm U1138, Institut Universitaire de France, Sorbonne Université, 75006, Paris, France.
Biology Direct
|November 1, 2023
Summary
Cancer immunotherapy utilizes dendritic cells (DC) to fight tumors. Conventional type 1 dendritic cells (cDC1) are crucial for activating anti-cancer immune responses, showing promise for new treatments.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Cancer immunotherapy has transformed cancer treatment.
- Dendritic cells (DC) are central to anti-tumor immunity.
- Conventional type 1 dendritic cells (cDC1) are vital for initiating anti-cancer immune responses.
Purpose of the Study:
- To review the characteristics of cDC1.
- To highlight the role of cDC1 in anticancer immunity.
- To explore cDC1-based immunotherapy strategies.
Main Methods:
- Literature review of cDC1 biology and function.
- Analysis of cDC1's role in antigen presentation and T cell activation.
- Synthesis of current and potential cDC1-based therapeutic approaches.
Main Results:
- cDC1 possess unique antigen-cross-presentation capabilities.
- cDC1 are essential for priming cytotoxic T lymphocyte responses against tumors.
- cDC1-based strategies offer a promising avenue for cancer immunotherapy.
Conclusions:
- cDC1 are key regulators of anti-tumor immunity.
- Understanding cDC1 biology is crucial for developing effective cancer immunotherapies.
- Targeting cDC1 holds significant therapeutic potential in oncology.
More Related Videos
Related Concept Videos
01:40Cell-mediated Immune Responses
68.6K
Overview
68.6K
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:27Cytotoxic T Cells-mediated Immune Response
928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928
01:30Cancer Vaccines
380
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
380
01:22T Cell Activation and Clonal Selection
753
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
753
01:26Antigens Involved in Adaptive Immunity
507
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
507